NAUT Q2 2023 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$19M

Net Income

-$16M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$331M

Total Liabilities

$41M

Stockholders' Equity

$290M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$829,000	-71.3%
Operating Income	-$19M	-$15M	-22.9%
Net Income	-$16M	-$15M	-7.6%